BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30160976)

  • 1. Where the Chromosome Ends: Telomeres and Cytomegalovirus Risk in Lung Transplant Recipients.
    Greenland JR
    Am J Respir Crit Care Med; 2019 Feb; 199(3):265-267. PubMed ID: 30160976
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
    Popescu I; Mannem H; Winters SA; Hoji A; Silveira F; McNally E; Pipeling MR; Lendermon EA; Morrell MR; Pilewski JM; Hanumanthu VS; Zhang Y; Gulati S; Shah PD; Iasella CJ; Ensor CR; Armanios M; McDyer JF
    Am J Respir Crit Care Med; 2019 Feb; 199(3):362-376. PubMed ID: 30088779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Hypoxemic Respiratory Failure and Native Lung Idiopathic Pulmonary Fibrosis Exacerbation in Single-lung Transplant Patients with Cytomegalovirus Disease: A Case Series.
    Marron RM; Vega Sanchez ME; Clauss H; Mamary AJ
    Transplant Proc; 2019 Dec; 51(10):3391-3394. PubMed ID: 31733804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation.
    Courtwright AM; Fried S; Villalba JA; Moniodis A; Guleria I; Wood I; Milford E; Mallidi HH; Hunninghake GM; Raby BA; Agarwal S; Camp PC; Rosas IO; Goldberg HJ; El-Chemaly S
    PLoS One; 2016; 11(9):e0162409. PubMed ID: 27589328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
    Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
    Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.
    Rittà M; Costa C; Solidoro P; Sidoti F; Libertucci D; Boffini M; Rinaldi M; Baldi S; Cavallo R
    Antiviral Res; 2015 Jan; 113():19-26. PubMed ID: 25446337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway complications in lung transplant recipients with telomere-related interstitial lung disease.
    Choi B; Messika J; Courtwright A; Mornex JF; Hirschi S; Roux A; Le Pavec J; Quêtant S; Froidure A; Lazor R; Reynaud-Gaubert M; Borgne AL; Houlbracq MP; Goldberg H; El-Chemaly S; Borie R;
    Clin Transplant; 2022 Mar; 36(3):e14552. PubMed ID: 34856024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
    Santos CA; Brennan DC; Yusen RD; Olsen MA
    Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.
    Monforte V; Sintes H; López-Gallo C; Delgado M; Santos F; Zurbano F; Solé A; Gavaldá J; Borro JM; Redel-Montero J; Cifrian JM; Pastor A; Román A; Ussetti P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28294487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
    Mabilangan C; Preiksaitis J; Cervera C;
    Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels.
    Weseslindtner L; Görzer I; Roedl K; Küng E; Jaksch P; Klepetko W; Puchhammer-Stöckl E
    Transplantation; 2017 Jan; 101(1):197-203. PubMed ID: 26910332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in lung transplant recipients.
    Almaghrabi RS; Omrani AS; Memish ZA
    Expert Rev Respir Med; 2017 May; 11(5):377-383. PubMed ID: 28388307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection in seromismatched lung transplant recipients with and without prophylaxis with CMV immunoglobulin.
    Kathawalla SA; Stillwell PC; Gordon S; Haug M; Perl M; Arroliga AC; Mehta AC; Avery R; Kirby T
    Transplant Proc; 1996 Dec; 28(6 Suppl 2):16. PubMed ID: 9037272
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients.
    Spivey JF; Singleton D; Sweet S; Storch GA; Hayashi RJ; Huddleston CB; Danziger-Isakov LA
    Pediatr Transplant; 2007 May; 11(3):312-8. PubMed ID: 17430489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.
    Gagermeier JP; Rusinak JD; Lurain NS; Alex CG; Dilling DF; Wigfield CH; Love RB
    Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
    Jaamei N; Koutsokera A; Pasquier J; Mombelli M; Meylan P; Pascual M; Aubert JD; Manuel O
    Transpl Infect Dis; 2018 Aug; 20(4):e12893. PubMed ID: 29603543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    Mihm J; Leyking S; Dirks J; Smola S; Fliser D; Sester U; Sester M; Wilkens H; Rissland J
    J Clin Virol; 2016 Sep; 82():5-8. PubMed ID: 27389910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently listed for single and double lung transplantation.
    Chauhan D; Karanam AB; Merlo A; Tom Bozzay PA; Zucker MJ; Seethamraju H; Shariati N; Russo MJ
    J Heart Lung Transplant; 2016 May; 35(5):657-60. PubMed ID: 26856664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.